Form 8-K - Current report:
SEC Accession No. 0001437749-21-024532
Filing Date
2021-10-28
Accepted
2021-10-28 16:15:02
Documents
14
Period of Report
2021-10-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lmat20211028_8k.htm   iXBRL 8-K 29632
2 EXHIBIT 99.1 ex_298793.htm EX-99.1 220305
  Complete submission text file 0001437749-21-024532.txt   398211

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lmat-20211028.xsd EX-101.SCH 3594
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lmat-20211028_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lmat-20211028_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lmat-20211028_pre.xml EX-101.PRE 11585
7 EXTRACTED XBRL INSTANCE DOCUMENT lmat20211028_8k_htm.xml XML 2549
Mailing Address 63 SECOND AVENUE BURLINGTON MA 01803
Business Address 63 SECOND AVENUE BURLINGTON MA 01803 781-221-2266
LEMAITRE VASCULAR INC (Filer) CIK: 0001158895 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33092 | Film No.: 211358394
SIC: 3841 Surgical & Medical Instruments & Apparatus